Literature DB >> 27556578

Anti-inflammatory signaling during ex vivo liver perfusion improves the preservation of pig liver grafts before transplantation.

Nicolas Goldaracena1, Juan Echeverri1,2, Vinzent N Spetzler1, Johan M Kaths1, Andrew S Barbas1, Kristine S Louis1, Oyedele A Adeyi3, David R Grant1, Nazia Selzner4, Markus Selzner5.   

Abstract

Normothermic ex vivo liver perfusion (NEVLP) improves graft preservation by avoiding cold ischemia injury. We investigated whether the protective effects of NEVLP can be further improved by applying strategies targeted on reducing the activation of proinflammatory cytokines during perfusion. Livers retrieved under heart-beating conditions were perfused for 4 hours. Following the preservation period, a pig liver transplantation was performed. In group 1 (n = 5), anti-inflammatory strategies (alprostadil, n-acetylcysteine, carbon monoxide, sevoflurane, and subnormothermic temperature [33°C]) were applied. This was compared with a perfused control group (group 2) where livers (n = 5) were perfused at 37°C without anti-inflammatory agents, similar to the setup used in current European clinical trials, and to a control group preserved with static cold storage (group 3). During 3-day follow-up, markers of reperfusion injury, bile duct injury, and liver function were examined. Aspartate aminotransferase (AST) levels during perfusion were significantly lower in the study versus control group at 1 hour (52 ± 6 versus 162 ± 86 U/L; P = 0.01), 2 hours (43 ± 5 versus 191 ± 111 U/L; P = 0.008), and 3 hours (24 ± 16 versus 218 ± 121 U/L; P = 0.009). During perfusion, group 1 versus group 2 had reduced interleukin (IL) 6, tumor necrosis factor α, and galactosidase levels and increased IL10 levels. After transplantation, group 1 had lower AST peak levels compared with group 2 and group 3 (1400 ± 653 versus 2097 ± 1071 versus 1747 ± 842 U/L; P = 0.47) without reaching significance. Bilirubin levels were significantly lower in group 1 versus group 2 at day 1 (3.6 ± 1.5 versus 6.60 ± 1.5 μmol/L; P = 0.02) and 3 (2 ± 1.1 versus 9.7 ± 7.6 μmol/L; P = 0.01). A trend toward decreased hyaluronic acid, as a marker of improved endothelial cell function, was observed at 1, 3, and 5 hours after reperfusion in group 1 versus group 2. Only 1 early death occurred in each group (80% survival). In conclusion, addition of anti-inflammatory strategies further improves warm perfused preservation. Liver Transplantation 22 1573-1583 2016 AASLD.
© 2016 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27556578     DOI: 10.1002/lt.24603

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  25 in total

Review 1.  The dawn of liver perfusion machines.

Authors:  Danielle Detelich; James F Markmann
Journal:  Curr Opin Organ Transplant       Date:  2018-04       Impact factor: 2.640

Review 2.  Organ preservation: from the past to the future.

Authors:  Lei Jing; Leeann Yao; Michael Zhao; Li-Ping Peng; Mingyao Liu
Journal:  Acta Pharmacol Sin       Date:  2018-03-22       Impact factor: 6.150

3.  The Immunological Effect of Oxygen Carriers on Normothermic Ex Vivo Liver Perfusion.

Authors:  Heather Jennings; Kristin N Carlson; Chris Little; Joshua C Verhagen; Jeevan Nagendran; Yongjun Liu; Bret Verhoven; Weifeng Zeng; Stacey McMorrow; Peter Chlebeck; David P Al-Adra
Journal:  Front Immunol       Date:  2022-06-22       Impact factor: 8.786

4.  Normothermic ex vivo liver perfusion: platform for liver graft assessment and therapeutic modification.

Authors:  Corey Eymard; James Markmann
Journal:  Organogenesis       Date:  2018-10-05       Impact factor: 2.500

Review 5.  Therapeutics administered during ex vivo liver machine perfusion: An overview.

Authors:  Julianna E Buchwald; Jing Xu; Adel Bozorgzadeh; Paulo N Martins
Journal:  World J Transplant       Date:  2020-01-18

6.  Severity of early allograft dysfunction following donation after circulatory death liver transplantation: a multicentre study.

Authors:  Kun Wang; Di Lu; Yuhui Liu; Wangyao Li; Li Zhuang; Zhenyu Ma; Qinfen Xie; Binhua Pan; Yichao Wu; Junli Chen; Lidan Lin; Xiaowen Feng; Qiang Wei; Xuyong Wei; Haiyang Xie; Zhengxin Wang; Shusen Zheng; Xiao Xu
Journal:  Hepatobiliary Surg Nutr       Date:  2021-01       Impact factor: 7.293

7.  Dual versus single vessel normothermic ex vivo perfusion of rat liver grafts using metamizole for vasodilatation.

Authors:  Felix Claussen; Joseph M G V Gassner; Simon Moosburner; David Wyrwal; Maximilian Nösser; Peter Tang; Lara Wegener; Julian Pohl; Anja Reutzel-Selke; Ruza Arsenic; Johann Pratschke; Igor M Sauer; Nathanael Raschzok
Journal:  PLoS One       Date:  2020-07-02       Impact factor: 3.240

8.  Pharmacological Activating Transcription Factor 6 Activation Is Beneficial for Liver Retrieval With ex vivo Normothermic Mechanical Perfusion From Cardiac Dead Donor Rats.

Authors:  Nuo Cheng; Ji-Hua Shi; Yang Jin; Yuan-Bin Shi; Xu-Dong Liu; Hua-Peng Zhang; Sheng-Li Cao; Han Yang; Wen-Zhi Guo; Shui-Jun Zhang
Journal:  Front Surg       Date:  2021-06-18

9.  The ultrastructural characteristics of porcine hepatocytes donated after cardiac death and preserved with warm machine perfusion preservation.

Authors:  Hiroki Bochimoto; Naoto Matsuno; Yo Ishihara; Tatsuya Shonaka; Daisuke Koga; Yoshiki Hira; Yuji Nishikawa; Hiroyuki Furukawa; Tsuyoshi Watanabe
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

10.  Opportunities for Therapeutic Intervention During Machine Perfusion.

Authors:  Negin Karimian; Heidi Yeh
Journal:  Curr Transplant Rep       Date:  2017-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.